| Next 10 |
Ad
ENZC News and Press Enzolytics Inc
News | Enzolytics Inc (OTCMKTS:ENZC)
-
Provides Updates on SAGA Transaction and on Virogentics, Inc. and Biogenysis, Inc. Progress ALLEN, TX / ACCESSWIRE / November 20, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com /" https://enzolytics.com/ ). Enzolytics, Inc. (the "Company") filed an amended December 31, 2022...
-
2023-09-18 08:33:41 ET More on Enzolytics, Inc. Financial information for Enzolytics, Inc. SPAC Sagaliam, Enzolytics agree to raise price of unit sale to $450M For further details see: Enzolytics sells its units to Sagaliam Acquisition
-
COLLEGE STATION, TX / ACCESSWIRE / September 18, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com ). Enzolytics, Inc. announces today that it has executed the binding business combination agreement for the sale of Biogenysis, Inc. ("BGEN") and Virogentics Inc. ("VIRO"), the oper...
-
New York, NY, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: “SAGAU”, “SAGA”, “SAGAR”) (“ we ”, “ us ”, “ our ”, or the “ Compan y”) announced today that it re...
-
Start date is expected by the end of 2023 / beginning of 2024. VIRO also offers an update on Diabetic trials and Sagaliam transaction. ALLEN, TX / ACCESSWIRE / September 6, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com/ ). Virogentics, Inc. ("VIRO"), a wholly owned subsid...
-
COLLEGE STATION, TX / ACCESSWIRE / September 5, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com/ ). Biogenysis, Inc. ("BGEN"), a wholly owned subsidiary of Enzolytics, Inc. (the "Company" or "ENZC"), a drug development biotech company, announced today a continued partnership wi...
-
COLLEGE STATION, TX / ACCESSWIRE / August 24, 2023 / Biogenysis, Inc. (OTC PINK:ENZC) (or the "Company"). Biogenysis, a subsidiary of Enzolytics, Inc., announces the progress of its Patent Cooperation Treaty (PCT) application covering its inventions relating to Anti-SARS-CoV-2 Monoclonal Antibod...
-
Reports on Business combination agreement progress ALLEN, TX / ACCESSWIRE / August 8, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com/ ). Virogentics, Inc. ("VIRO") a wholly owned subsidiary of Enzolytics, Inc. (the "Company" or "ENZC"), a drug development biotech company, ...
-
Progress on Sagaliam Acquisition Corp Transaction ALLEN, TX / ACCESSWIRE / August 4, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com/ ). Virogentics, Inc. ("VIRO"), a wholly owned subsidiary of Enzolytics, Inc. (the "Company" or "ENZC"), a drug development biotech company, ...
-
Expects to Issue Update on EMA Progress ALLEN, TX / ACCESSWIRE / July 24, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com/ ). CORRECTED Virogentics, Inc. ("VIRO") a wholly owned subsidiary of Enzolytics, Inc. (the "Company" or "ENZC"), a drug development biotech company, an...
Stock Information
Get ENZC Alerts
News, Short Squeeze, Breakout and More Instantly...
Enzolytics Inc Company Name:
ENZC Stock Symbol:
OTCMKTS Market:
Ad
-
Provides Updates on SAGA Transaction and on Virogentics, Inc. and Biogenysis, Inc. Progress ALLEN, TX / ACCESSWIRE / November 20, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com /" https://enzolytics.com/ ). Enzolytics, Inc. (the "Company") filed an amended December 31, 2022...
-
COLLEGE STATION, TX / ACCESSWIRE / September 18, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com ). Enzolytics, Inc. announces today that it has executed the binding business combination agreement for the sale of Biogenysis, Inc. ("BGEN") and Virogentics Inc. ("VIRO"), the oper...
-
New York, NY, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: “SAGAU”, “SAGA”, “SAGAR”) (“ we ”, “ us ”, “ our ”, or the “ Compan y”) announced today that it re...